NCT03304340

Brief Summary

The purpose of this study was to examine the outcomes of postural stability, activities of daily living function, and motor capacity of persons after stroke who received transcutaneous electrical nerves stimulation (TENS) or functional electrical stimulation (FES), in addition to SR, in the post-stroke acute phase. Such persons were compared with others who received SR alone in order to determine if the addition of TENS or FES resulted in earlier or more effective recovery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 25, 2015

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2015

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

October 1, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 9, 2017

Completed
Last Updated

October 9, 2017

Status Verified

September 1, 2017

Enrollment Period

9 months

First QC Date

October 1, 2017

Last Update Submit

October 5, 2017

Conditions

Keywords

acute stroke,TENS ,posture stability, function

Outcome Measures

Primary Outcomes (1)

  • The score-change of the Functional Independence Measure (FIM) for activity of daily living function

    The FIM with a maximum score of 116 was used to assess each patient's capacities in terms of ADL, which comprises 18 seven-level items and assesses dependence in self-care, sphincter management, transfer, locomotion, communication, social interaction and cognition.

    baseline and 2-week, 4-week after stroke

Secondary Outcomes (7)

  • Modified Ashworth scale for affected ankle plantar-flexors spasticity measurement

    baseline and 2-week, 4-week after stroke

  • Maximum isometric voluntary contraction (MIVC) of hip flexors, knee extensors and ankle dorsiflexors for measuring the improvement of affected muscle strength

    baseline and 2-week, 4-week after stroke

  • the Timed Up & Go (TUG) test for functional mobility ability

    baseline and 2-week, 4-week after stroke

  • the 10-meters walking test (10MWT) for walking speed evaluation

    baseline and 2-week, 4-week after stroke

  • The number of days required to achieve 5-mins sitting motor milestones from the Postural Assessment Scale for Stroke Patients (PASS)

    within 4 weeks from stroke onset

  • +2 more secondary outcomes

Study Arms (3)

TENS+SR

EXPERIMENTAL

For each participant in the transcutaneous nerve stimulation (TENS) group, standard rehabilitation (SR) in addition a TENS stimulator (BioTENS, Skylark Device \& Systems Co., Ltd) was applied with 0.2-ms pulses at 100 Hz in the constant mode within the subject's sensory level without muscle contraction via (5 × 3.5 cm) electrodes attached to the motor points of the tibia anterior (TA) and quadriceps muscles on the affected lower extremity. For the TENS group, the given electric stimulation treatment lasted for 30 min per session, once per day, 5 days a week, for 2 weeks.

Device: transcutaneous nerve stimulation (TENS)Other: standard rehabilitation (SR)

FES + SR

EXPERIMENTAL

For each participant in the functional electrical stimulation (FES) group, standard rehabilitation (SR) in addition two dual-channel FES stimulators (MEDTRONIC Respond Select; EmpiInc) were used. The FES was delivered with 0.3-ms pulses at 30 pps and the stimulation intensity was set to the movement threshold to induce visible muscle contractions. For the FES group, the given electric stimulation treatment lasted for 30 min per session, once per day, 5 days a week, for 2 weeks.

Device: functional electrical stimulation (FES)Other: standard rehabilitation (SR)

SR-only

ACTIVE COMPARATOR

All the participants received functional training and motor relearning physiotherapy treatment as early standard rehabilitation (SR) for 30 minutes per day, 5 days a week throughout the study. Subjects in the SR group received only SR .

Other: standard rehabilitation (SR)

Interventions

Two dual-channel stimulators (MEDTRONIC Respond Select;Empi Inc) were connected with a program timer to form one stimulating unit for functional electrical stimulation (FES). FES was delivered with 0.3-ms pulses at 30 Hz, maximum tolerance intensity about 20 to 30 mA to cause visible muscle contraction.

FES + SR

Transcutaneous nerve stimulation (TENS) stimulator (BioTENS, Skylark Device \& Systems Co., Ltd,) was applied with 0.2 ms pulses, at 100 Hz in the constant mode within the subject'sensory level without muscle contraction, via (5 × 3.5 cm) electrodes attached to the motor points of quadriceps and tibialis anterior (TA) on the affected lower extremity.

TENS+SR

The standard rehabilitation (SR) program was a part of a regular intervention in stroke center. The activities of SR performed including neurodevelopment facilitation techniques, range of motion exercises and movement re-learning exercises etc.

FES + SRSR-onlyTENS+SR

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • the patient who suffer from first stroke was admitted to the stroke center of National Taiwan University Hospital (NTUH) within 3 days of onset
  • National Institutes of Health Stroke Scale (NIHSS) scores ranging from 5 to 25
  • totally activity of daily living independent before stroke onset;
  • between 40-80 years old;
  • stroke with unilateral hemiparesis lesions confirmed by magnetic resonance imaging (MRI) or computed tomography (CT), with vascular lesions verified by magnetic resonance angiography (MRA);
  • a cortical or subcortical infarction or hemorrhage;
  • no other peripheral or central nervous system dysfunction;
  • no active inflammation or pathologic changes in the joints;
  • no active medical problems.

You may not qualify if:

  • medical conditions unrelated to the cerebrovascular accident but which had affected walking performance
  • other cognitive, emotional, or behavioral impairments that result in insufficient comprehension, understanding, or collaboration
  • medical problems potentially adversely affected by electric stimulation
  • had skin conditions, or had allergies etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, Test2, test3, Taiwan

Location

MeSH Terms

Interventions

Transcutaneous Electric Nerve Stimulation

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Study Officials

  • Jer-Junn Lun, PhD

    School institute of Physical Therapy, National Taiwan University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2017

First Posted

October 9, 2017

Study Start

March 25, 2015

Primary Completion

December 31, 2015

Study Completion

December 31, 2015

Last Updated

October 9, 2017

Record last verified: 2017-09

Locations